Overweight with Comorbidities For individuals with BMI 27-30 who have metabolic complications type 2 diabetes, MASLD, dyslipidemia, hypertension retatrutide's multi-system benefits address multiple conditions simultaneously rather than treating each one separately
Kosiborod MN, Abildstrom SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, et al
Researchers attribute this rise in exposures to increases in prescriptions for these medications and an increase in therapeutic errors
Alexander Shapsis of EndoSlim Clinic at Atlantic Gastroenterology dives into four key ways in which this shift is affecting those with diabetes: 1
The GLP-1 Revolution: Insights for food and beverages May 2025, Euromonitor International 3
Real Patient Results This is why we track body composition, not just weight